A Study of Lasmiditan and Propranolol in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2017

Primary Completion Date

November 22, 2017

Study Completion Date

November 22, 2017

Conditions

Healthy

Interventions

DRUG

Lasmiditan

Administered orally

DRUG

Propranolol

Administered orally

Trial Locations (1)

Covance Daytona Beach, Daytona Beach

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT03270644 - A Study of Lasmiditan and Propranolol in Healthy Participants | Biotech Hunter | Biotech Hunter